Woodstock Corp’s Aratana Therapeutics, Inc. PETX Stock Holding History

Woodstock Corp’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-88,303	Closed	-$541K	–	167
2017 Q3	$541K	Buy	88,303 +16,397	+23%	+$104K	0.1%	113
2017 Q2	$520K	Hold	71,906	–	–	0.1%	118
2017 Q1	$381K	Buy	71,906 +39,226	+120%	+$265K	0.08%	129
2016 Q4	$235K	Sell	32,680 -6,664	-17%	-$53.9K	0.05%	145
2016 Q3	$368K	Hold	39,344	–	–	0.08%	124
2016 Q2	$249K	Buy	39,344 +11	+0%	+$71	0.05%	140
2016 Q1	$217K	Hold	39,333	–	–	0.05%	145
2015 Q4	$219K	Hold	39,333	–	–	0.05%	140
2015 Q3	$333K	Hold	39,333	–	–	0.08%	118
2015 Q2	$595K	Hold	39,333	–	–	0.11%	113
2015 Q1	$630K	Buy	+39,333	New	+$700K	0.12%	111

Other funds holding PETX

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Woodstock Corp's PETX Position: Q4 2017 in Review

Woodstock Corp sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2017, closing a stake of 88,303 shares — an estimated $541K sold.

Woodstock Corp first reported a position in PETX in Q1 2015 and held it in 11 quarters. The position peaked at $630K in Q1 2015. 105 funds tracked by Wall St. Rank hold PETX as of Q4 2017.

Woodstock Corp reported no remaining Aratana Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Woodstock Corp sold 88,303 Aratana Therapeutics, Inc. shares in Q4 2017, an estimated $541K.
Woodstock Corp first reported a position in Aratana Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
Woodstock Corp's Aratana Therapeutics, Inc. position peaked at $630K in Q1 2015.
105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2017.

Based on Woodstock Corp's 13F filing for Q4 2017, filed 24 Jan 2018.